| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 630 | 0 | 1.242 | 4.260 | 0 | 0 | 6.646 | 0 | 6.322 |
| Total Income - EUR | 2.677 | 630 | 1 | 1.242 | 4.260 | 0 | 0 | 369.815 | 0 | 6.658 |
| Total Expenses - EUR | 20.874 | 5.275 | 9.931 | 26.820 | 30.423 | 7.296 | 30.254 | 179.040 | 10.236 | 42.144 |
| Gross Profit/Loss - EUR | -18.197 | -4.645 | -9.930 | -25.578 | -26.163 | -7.296 | -30.254 | 190.775 | -10.236 | -35.486 |
| Net Profit/Loss - EUR | -18.277 | -4.664 | -36.267 | -25.616 | -26.291 | -7.296 | -30.254 | 187.532 | -10.236 | -35.486 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Nevromedsan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 215.004 | 212.812 | 209.211 | 205.371 | 195.436 | 191.538 | 186.536 | 8.674 | 7.893 | 7.098 |
| Current Assets | 84.982 | 84.670 | 84.954 | 81.965 | 80.919 | 78.578 | 78.700 | 78.142 | 76.962 | 81.260 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.634 |
| Receivables | 84.932 | 84.065 | 83.113 | 81.551 | 79.971 | 78.455 | 76.715 | 76.285 | 76.087 | 76.022 |
| Cash | 50 | 604 | 1.841 | 415 | 948 | 123 | 1.984 | 1.857 | 875 | 1.604 |
| Shareholders Funds | -276.826 | -278.667 | -310.490 | -330.408 | -350.300 | -350.955 | -373.426 | -199.674 | -209.304 | -243.620 |
| Social Capital | 59.100 | 58.497 | 57.507 | 56.452 | 55.359 | 54.309 | 53.105 | 53.270 | 53.108 | 52.811 |
| Debts | 511.673 | 576.148 | 541.271 | 555.524 | 565.639 | 561.211 | 580.130 | 286.490 | 294.159 | 331.979 |
| Income in Advance | 65.139 | 64.475 | 63.384 | 62.221 | 61.016 | 59.859 | 58.532 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5510 - 5510" | |||||||||
| CAEN Financial Year |
5590
|
|||||||||
Comments - Nevromedsan Srl